Full archive
Bioinformatics & AI
Week of 16 June 2026
12 articles
Geno'X Veille — genox-veille.fr
Key takeaways this week
- ►Genomic LLM — A fine-tuned genomic language model outperforms standard missense pathogenicity predictors by capturing nucleotide-level information (bioRxiv).
- ►Q40 sequencing — Q40 sequencing significantly improves rare variant detection at reduced depth, validated on certified reference materials (Genome Biology).
- ►LLMs vs clinical AI — General-purpose LLMs (GPT-5.2, Gemini 3.1 Pro, Claude Opus 4.6) outperform specialized clinical AI tools on standardized medical benchmarks (Nature Medicine).
- ►SWARM nanopore — SWARM resolves RNA modification interference on nanopore and opens the door to multi-modification diagnostic epitranscriptomics (bioRxiv).
Category:
Filters··Min. score
12 articles of 12
Sort
Algorithm benchmark
bioRxiv★ Top pick
A fine-tuned genomic language model captures nucleotide-level information overlooked by missense variant impact predictors.
Missense variant interpretation / pathogenicity prediction
0
/10
Algorithm benchmarkNew toolPathogenicity prediction
bioRxiv 2026· JunRead
Algorithm benchmark
PubMed★ Top pick
Benchmarking Q40 sequencing for sensitive and efficient detection of rare genomic variants.
Rare variant detection / sequencing quality
0
/10
Algorithm benchmarkBenchmarkClinical pipeline
Genome Biol 2026· JunRead
Epigenomic annotation / noncoding variant interpretation
PubMed★ Top pick
Pan-cell type continuous chromatin state annotation of all epigenomes from the International Human Epigenome Consortium.
Epigenomic annotation / noncoding variant interpretation
0
/10
New toolPathogenicity prediction
Genome Biol 2026· JunRead
Transcriptomics pipelines / diagnostic RNA-seq
bioRxivSTAR Suite: Transcriptomics processing in a single binary through AI-assisted development.
Transcriptomics pipelines / diagnostic RNA-seq
0
/10
New toolClinical pipeline
bioRxiv 2026· JunRead
Long-read
bioRxivSWARM resolves nanopore signal interference between RNA modification types and reveals splicing-shaped pseudouridylation.
Epitranscriptomic modifications / direct RNA nanopore sequencing
0
/10
Long-readNew toolLong-read sequencing
bioRxiv 2026· JunRead
Algorithm benchmark
PubMedEvaluating the role of pretraining dataset size and diversity on single-cell foundation model performance.
Single-cell foundation models / transcriptomics
0
/10
Algorithm benchmarkNew toolBenchmark
Nat Methods 2026· JunRead
Algorithm benchmark
PubMedTowards robust foundation models for digital pathology.
Digital pathology / foundation model robustness
0
/10
Algorithm benchmarkNew toolBenchmark
Nat Commun 2026· JunRead
SRY
PubMedCombined optical genome mapping and CNV-seq identify complex Y-chromosome rearrangements and ectopy in 46,XX testicular disorder of sex development.
46,XX testicular disorder of sex development / complex Y-chromosome rearrangements
0
/10
New toolSV caller
Mol Cytogenet 2026· JunRead
Long-read
PubMedSpatially resolved m6A profiling across tissues using m6A-ARTR-DBiT.
Spatial epitranscriptomics / m6A modification
0
/10
Long-readNew toolLong-read sequencing
Nat Methods 2026· JunRead
Newborn screening / genomics
PubMedGenomics to Enhance Newborn Screening?
Newborn screening / genomics
0
/10
BenchmarkClinical pipeline
Genet Med 2026· JunRead
Algorithm benchmark
PubMed⭐ À la une
General-purpose large language models outperform specialized clinical AI tools on medical benchmarks.
Clinical AI / LLMs in medicine
0
/10
Algorithm benchmarkBenchmarkLLM applied
Nat Med 2026· JunRead
Preimplantation genetic testing for monogenic disorders (PGT-M)
PubMedSystematic assessment of allele dropout in preimplantation genetic testing for monogenic disorders: Incidence, detection, and clinical testing strategies.
Preimplantation genetic testing for monogenic disorders (PGT-M)
0
/10
BenchmarkClinical pipeline
Fertil Steril 2026· JunRead
References and sources
- Missense variant interpretation / pathogenicity prediction. bioRxiv 2026. doi:10.64898/2026.05.06.723362. Score 9/10. https://www.biorxiv.org/content/10.64898/2026.05.06.723362v2
- Rare variant detection / sequencing quality. Genome Biol 2026. PMID 42286715. Score 9/10. https://pubmed.ncbi.nlm.nih.gov/42286715/
- Epigenomic annotation / noncoding variant interpretation. Genome Biol 2026. PMID 42271487. Score 9/10. https://pubmed.ncbi.nlm.nih.gov/42271487/
- Transcriptomics pipelines / diagnostic RNA-seq. bioRxiv 2026. doi:10.64898/2026.03.09.710580. Score 8/10. https://www.biorxiv.org/content/10.64898/2026.03.09.710580v2
- Epitranscriptomic modifications / direct RNA nanopore sequencing. bioRxiv 2026. doi:10.64898/2025.12.18.695332. Score 8/10. https://www.biorxiv.org/content/10.64898/2025.12.18.695332v4
- Single-cell foundation models / transcriptomics. Nat Methods 2026. PMID 42265208. Score 8/10. https://pubmed.ncbi.nlm.nih.gov/42265208/
- Digital pathology / foundation model robustness. Nat Commun 2026. PMID 42277006. Score 8/10. https://pubmed.ncbi.nlm.nih.gov/42277006/
- SRY — 46,XX testicular disorder of sex development / complex Y-chromosome rearrangements. Mol Cytogenet 2026. PMID 42289734. Score 8/10. https://pubmed.ncbi.nlm.nih.gov/42289734/
- Spatial epitranscriptomics / m6A modification. Nat Methods 2026. PMID 42265211. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/42265211/
- Newborn screening / genomics. Genet Med 2026. PMID 42261752. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/42261752/
- Clinical AI / LLMs in medicine. Nat Med 2026. PMID 42286322. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/42286322/
- Preimplantation genetic testing for monogenic disorders (PGT-M). Fertil Steril 2026. PMID 42288235. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/42288235/